GSA Capital Partners LLP Has $116,000 Stock Position in agilon health, inc. (NYSE:AGL)

GSA Capital Partners LLP lessened its holdings in agilon health, inc. (NYSE:AGL) by 65.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,463 shares of the company’s stock after selling 56,448 shares during the period. GSA Capital Partners LLP’s holdings in agilon health were worth $116,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. J.Safra Asset Management Corp raised its holdings in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the last quarter. CWM LLC increased its stake in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after buying an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in shares of agilon health during the 2nd quarter worth approximately $60,000. Allspring Global Investments Holdings LLC grew its holdings in shares of agilon health by 17,790.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after acquiring an additional 10,674 shares in the last quarter. Finally, Pallas Capital Advisors LLC bought a new position in shares of agilon health in the second quarter valued at approximately $77,000.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on AGL. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Benchmark reissued a “buy” rating and issued a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Stifel Nicolaus lowered their price objective on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Finally, Citigroup reduced their target price on shares of agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research report on Wednesday, November 13th. Three investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $6.05.

Insider Activity

In related news, CEO Steven Sell acquired 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The shares were bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the transaction, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 3.20% of the company’s stock.

agilon health Stock Performance

Shares of AGL opened at $2.27 on Tuesday. agilon health, inc. has a 52-week low of $1.50 and a 52-week high of $13.76. The stock’s 50-day simple moving average is $2.86 and its 200 day simple moving average is $4.72. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market capitalization of $933.23 million, a price-to-earnings ratio of -2.41 and a beta of 0.60.

agilon health (NYSE:AGL) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter last year, the business posted ($0.06) earnings per share. Research analysts forecast that agilon health, inc. will post -0.47 EPS for the current fiscal year.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.